Health Management Associates (HMA) partners local communities to provide outstanding health care services. HMA manages a portfolio of 60 hospitals in 15 states. HMA empowers its hospitals and physician partners with the resources and expertise they need to fulfill their local missions of delivering superior health care services.
InterWest invested in this company in 1993, when it refocused its business on a "hospital-within-hospital" model for providing subacute transitional health care services for long-term patients with a tailored mix of services to maximize outcome. ATH was acquired by Beverly in 1994.
Ventritex established itself in the 1980s as a leading maker of implantable defibrillators, surgically implanted devices that automatically correct potentially lethal abnormal heart rhythms known as cardiac arrhythmias. Ventritex completed an IPO in 1993, and was acquired by St. Jude Medical in 1997.
Ventana discovers, develops, and delivers medical diagnostic systems and biopsy-based cancer tests. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 200 cancer tests for the four million people afflicted with cancer annually. Ventana completed an IPO in 1995 and was acquired by The Roche Group in 2008. The company still operates under the Ventana name.
Urologix develops, manufactures and markets minimally-invasive medical products for the treatment of urological disorders. The company has developed non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH). Its less-invasive technology has been used on more than 225,000 patients, establishing Urologix as a clear leader in BPH treatment.
TheraSense was a medical device company in Alameda, California developing two new product lines to dramatically change the way people with diabetes test and monitor their glucose levels. TheraSense was acquired by Abbott Laboratories in April 2004.
Spinal Dynamics was a medical device company that developed one of the leading artificial disk implants, Aeto, to replace natural intervertebral disks damaged by degenerative joint disease. The company was acquired by Medtronic in 2002.
PercuSurge pioneered a new market segment in interventional cardiology products with a series of balloon catheters designed to trap and remove the potentially harmful debris that breaks loose during balloon angioplasty and stent placement procedures. The company was acquired by Medtronic in 2000.
Nanogen's advanced technologies provided researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately, help treat disease. The company's products included real-time PCR reagents, the NanoChip(R) 400 electronic microarray platform and a line of rapid, point-of-care diagnostic tests. Nanogen was acquired by Epoch Biosciences in 2009.
LenSx Lasers developed a next-generation femtosecond laser that operates inside the eye to make cataract surgery safer and more effective. The founding team is the same team from IntraLase, a highly successful InterWest company that manufactured lasers for vision correction.